A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9 |

Conversely, injection forms, though being painful and needing help of medical personnel for application, help to quickly achieve necessary concentration of preparation in blood doxycycline online Antibiotic is usually chosen in an empiric way (at random). But when choosing one is obligatory guided by definite rules.

Microsoft word - cusjexamplemanuscriptspr06-df_3-14.doc

Example Research Article Submission Columbia Undergraduate Science Journal
Gabriel Morris
To the Founding Editor: Please find attached our original manuscript, "Do PAF-acetylhydrolase al elic variants affect plasma PAF-acetylhydrolase activity?", for your consideration for publication as a Research Article in the Columbia Undergraduate Science Journal. This work was completed when I was a student at White Station High School. No portion of this manuscript has been previously published or is under consideration for publication in another undergraduate This manuscript represents my contribution to the work of my faculty advisor on anti-inflammatory applications for platelet activating factor (PAF) acetylhydrolase, particularly how al elic variants of this enzyme may differ in anti-PAF activity. This manuscript should be of broad interest to the Columbia University community, with its use of biological
Gabriel Morris


Example Research Article Submission Columbia Undergraduate Science Journal Do PAF-acetylhydrolase allelic variants affect plasma PAF-acetylhydrolase activity?
White Station High School, Memphis, TN; 3Department of Pharmacy, University of Tennessee Health Science Center, Memphis, TN. Present address, Address for Correspondence: Department of Pharmacy, Columbia University, New York, NY. [email protected] Example Research Article Submission Columbia Undergraduate Science Journal Plasma platelet-activating factor (PAF) is a pro-inflammatory phospholipid mediator. Plasma PAF acetylhydrolase (PAF-AH) is an enzyme that degrades extracel ular PAF. Three al elic variants have been described for the PAF-AH gene: Arg92His, Ile198Thr, and Ala379Val. Genomic DNA was amplified in a newly developed, al ele specific real-time PCR-based genotyping method. Enzyme activity levels were determined using a fluorescence substrate. Therefore, in this study, PAF-AH specific genomic DNA al elic variants were analyzed and compared to plasma PAF-AH activity in controls and ARDS patients to determine if these variants affected plasma PAF-AH activity. Preliminary results indicate that PAF-AH activity is lower in ARDS patients (n=61) than in healthy controls (n=5), that PAF-AH is an indicator for ARDS severity, and the Arg92His variant leads to a reduced PAF-AH activity. This study has implications for better treatment of diseases such as ARDS, asthma, and other cardiovascular and inflammatory diseases. Key words: Clinical investigation; inflammation; plasma platelet activating factor; polymerase Example Research Article Submission Columbia Undergraduate Science Journal Citation Format (Using EndNote)
(Kruse et al., 2000) / (Stafforini et al., 1999) / (McIntyre et al., 1999) Example Research Article Submission Columbia Undergraduate Science Journal Kruse, S, Mao, X, Heinzmann, A, Blattman, S, Roberts, M, et al. (2000) The ile198thr and ala379val variants of plasmatic paf-acetylhydrolase impair catalytic activity and are associated with atopy and asthma. American Journal of Human Genetics 66 1422-1530.
McIntyre, T, Zimmerman, G, Makino, S, and Prescott, S (1999) Deficiency of platelet- activating factor acetyhydrolase is a severity factor for asthma. Journal of Clinical Investigation 102 989-997.
Stafforini, D, Numan, T, Tsodikov, A, Vaitkus, D, Fukuda, T, et al. (1999) Deficiency of platelet-activating factor acetyhydrolase is a severity factor for asthma. Journal of Clinical Investigation 102 989-997.

Source: http://cusj.columbia.edu/pdf0607/CUSJExampleManuscriptSpr07.pdf